Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Medikaloka Hermina TbkISX:HEAL -0.55%76 Pretax Margin % is 9.58% as of Mar. 2026, which is 23% below its 10-year median of 12.45. GuruFocus rates ISX:HEAL with a GF Score™ of 76/100 and a GF Value™ of Rp1,582.89 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 664 Healthcare Providers & Services companies, PT Medikaloka Hermina Tbk ranks better than 70.48% on this metric.
The historical rank and industry rank for PT Medikaloka Hermina Tbk's Pretax Margin % or its related term are showing as below:
ISX:HEAL'
s Pretax Margin % Range Over the Past 10 Years
Min: 9.01 Med: 12.45 Max: 28.05
Current: 9.84
ISX:HEAL's Pretax Margin % is ranked better than 70.48% of 664
companies
in the Healthcare Providers & Services industry
Industry Median: 4.015
vs ISX:HEAL: 9.84
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
PT Medikaloka Hermina Tbk Pretax Margin % Related Terms
PT Medikaloka Hermina Tbk Pretax Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:HEAL vs HCA, THC, DVA: Pretax Margin % Comparison
For the Medical Care Facilities subindustry, PT Medikaloka Hermina Tbk's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Medikaloka Hermina Tbk Pretax Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, PT Medikaloka Hermina Tbk's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where PT Medikaloka Hermina Tbk's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Medikaloka Hermina Tbk (ISX:HEAL) has a Pretax Margin % of 9.58% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. This is 23% below median its historical median of 12.45. Over the past decade, PT Medikaloka Hermina Tbk's Pretax Margin % has ranged from 9.01 to 28.05. According to the industry distribution chart, PT Medikaloka Hermina Tbk ranks #196 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 29.5%.
Is PT Medikaloka Hermina Tbk's Pretax Margin % too high?
PT Medikaloka Hermina Tbk's current Pretax Margin % of 9.58% is 23% below median its 10-year median of 12.45. Over the past 10 years, this metric has ranged from a low of 9.01 to a high of 28.05. The Healthcare Providers & Services industry median Pretax Margin % is 4.02. PT Medikaloka Hermina Tbk's value of 9.58% is 138.6% above this industry median. Based on the distribution chart, PT Medikaloka Hermina Tbk ranks #196 out of 664 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, PT Medikaloka Hermina Tbk has a GF Score™ of 76/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Medikaloka Hermina Tbk's Pretax Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, PT Medikaloka Hermina Tbk ranks #196 out of 664 companies for Pretax Margin %. This puts PT Medikaloka Hermina Tbk in the upper half of its industry. The industry median Pretax Margin % is 4.02. PT Medikaloka Hermina Tbk's value of 9.58% is 138.6% above this benchmark. Historically, PT Medikaloka Hermina Tbk's own Pretax Margin % has ranged from 9.01 to 28.05 over the past decade. While the company's 10-year median is 12.45 vs. the industry median of 4.02, PT Medikaloka Hermina Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Healthcare Providers & Services company?
The median Pretax Margin % among Healthcare Providers & Services companies is 4.02, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a Pretax Margin % significantly above this median, while those in the bottom quartile fall well below. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Medikaloka Hermina Tbk's current Pretax Margin % of 9.58% is 138.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on PT Medikaloka Hermina Tbk and its competitors. For the Healthcare Providers & Services industry, the median Pretax Margin % is 4.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Medikaloka Hermina Tbk's current Pretax Margin % is 9.58%, which is 23% below median its own 10-year median of 12.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Medikaloka Hermina Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk (ISX:HEAL) is currently considered Significantly Undervalued. The stock's GF Value™ is Rp1,582.89, compared to a current price of Rp900.00 — trading 43.1% below its estimated fair value. The current Pretax Margin % is 9.58%, which is 23% below median its 10-year median of 12.45 and 138.6% above the Healthcare Providers & Services industry median of 4.02. PT Medikaloka Hermina Tbk's overall GF Score™ is 76/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For PT Medikaloka Hermina Tbk (ISX:HEAL), the current Pretax Margin % is 9.58% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Medikaloka Hermina Tbk (ISX:HEAL) Overvalued in 2026?
Based on GuruFocus' analysis, PT Medikaloka Hermina Tbk stock appears to be undervalued.
The current stock price of Rp900.00 is trading 43.1% below its estimated GF Value™ of Rp1,582.89.
GuruFocus considers PT Medikaloka Hermina Tbk to be Significantly Undervalued.
Key valuation signals for ISX:HEAL:
Pretax Margin %: 9.58% (23% below median its 10-year median of 12.45)
GF Value™: Rp1,582.89 vs. price of Rp900.00 (43.1% below fair value)
Industry Position: 138.6% above the Healthcare Providers & Services median (#196 of 664)
No single metric tells the full story. See the ISX:HEAL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Medikaloka Hermina Tbk is a private hospital group. It provides a range of medical services, including maternal and child health services, complex operating procedures, laboratory services, radiology facilities, and fertility treatments as well as general health services, pharmacies, diagnostic and emergency services. The company's geographical segment includes Kalimantan dan Sulawesi, Jawa, and Sumatera. It derives maximum revenue from the Jawa segment.
76GF Score
Get the complete analysis for ISX:HEAL
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:HEAL has been successfully added to your 
